IP Verse

Dosage Regimen For Anti-Mif Antibodies - EP3277718

The patent EP3277718 was granted to Baxalta on Mar 24, 2021. The application was originally filed on Mar 31, 2016 under application number EP16712899A. The patent is currently recorded with a legal status of "Revoked".

EP3277718

BAXALTA
Application Number
EP16712899A
Filing Date
Mar 31, 2016
Status
Revoked
Nov 11, 2022
Grant Date
Mar 24, 2021
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

SCORPIODec 24, 2021TEUTENADMISSIBLE

Patent Citations (14) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication NumberPublication Link
DESCRIPTIONUS2003235584
DESCRIPTIONUS6645493
DESCRIPTIONWO2009086920
DESCRIPTIONWO2013156473
DESCRIPTIONWO2014086916
INTERNATIONAL-SEARCH-REPORTWO0164749
INTERNATIONAL-SEARCH-REPORTWO02067862
INTERNATIONAL-SEARCH-REPORTWO2013156473
INTERNATIONAL-SEARCH-REPORTWO9817314
OPPOSITIONUS2003099653
OPPOSITIONUS2003235584
OPPOSITIONWO2009086920
OPPOSITIONWO2013156473
OPPOSITIONWO2014086916

Non-Patent Literature (NPL) Citations (29) New

NPL citations refer to non-patent references such as research papers, articles, or other publications cited during examination or opposition phases.

Citation PhaseReference TextLink
DESCRIPTION- ANGAL ET AL., MOL IMMUNOL., (1993), vol. 30, pages 105 - 108-
DESCRIPTION- BAUGH ET AL., CRIT CARE MED, (2002), vol. 30, pages 27 - 35-
DESCRIPTION- BLOOM ET AL., SCIENCE, (1966), vol. 153, pages 80 - 82-
DESCRIPTION- CALANDRA ET AL., J. LNFLAMM., (1995), vol. 47, pages 39 - 51-
DESCRIPTION- CALANDRA ET AL., NATURE, (1995), vol. 377, pages 68 - 71-
DESCRIPTION- CHOTHIA ET AL., J. MOL. BIOL., (1987), vol. 196, pages 901 - 917-
DESCRIPTION- CHOTHIA ET AL., NATURE, (1989), vol. 342, pages 878 - 883-
DESCRIPTION- DAVID ET AL., PNAS, (1966), vol. 56, pages 72 - 77-
DESCRIPTION- EISENHAUER ET AL., EUROPEAN JOURNAL OF CANCER, (2009), vol. 45, pages 228 - 247-
DESCRIPTION- GALAT ET AL., EUR. J. BIOCHEM, (1994), vol. 224, pages 417 - 421-
DESCRIPTION- "General Principles of Cancer Chemotherapy", GOODMAN; GILMAN, The Pharmacological Basis of Therapeutics. 12th ed.-
DESCRIPTION- "General Principles of Cancer Chemotherapy. Introduction", GOODMAN; GILMAN, The Pharmacological Basis of Therapeutics-
DESCRIPTION- KAWAGUCHI ET AL., LEUKOC. BIOL., (1986), vol. 39, pages 223 - 232-
DESCRIPTION- LUE, H. ET AL., ONCOGENE, (2007), vol. 26, no. 35, pages 5046 - 5059-
DESCRIPTION- MITCHELL, R.A., CELLULAR SIGNALLING, (2004), vol. 18, no. 1, pages 13 - 19-
DESCRIPTION- NISHIHIRA ET AL., J INTERFERON CYTOKINE RES., (2000), vol. 20, pages 751 - 762-
DESCRIPTION- SHIMIZU ET AL., FEBS LETT., (1996), vol. 381, pages 199 - 202-
DESCRIPTION- SUN ET AL., PNAS, (1996), vol. 93, pages 5191 - 5196-
DESCRIPTION- WATARAI ET AL., PNAS, (2000), vol. 97, pages 13251 - 13256-
DESCRIPTION- WEISER ET AL., CELL. LMMUNOL., (1985), vol. 90, pages 167 - 178-
DESCRIPTION- WEISER ET AL., PNAS, (1989), vol. 86, pages 7522 - 7526-
INTERNATIONAL-SEARCH-REPORT- SHIMIZU T ET AL, "HIGH EXPRESSION OF MACROPHAGE MIGRATION INHIBITORY FACTOR IN HUMAN MELANOMA CELLS AND ITS ROLE IN TUMOR CELL GROWTH AND ANGIOGENESIS", BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, ACADEMIC PRESS INC. ORLANDO, FL, US, (19991102), vol. 264, no. 3, doi:10.1006/BBRC.1999.1584, ISSN 0006-291X, pages 751 - 758, XP001008703 [A] 1-36 * the whole document *
INTERNATIONAL-SEARCH-REPORT- F. HUSSAIN ET AL, "Human Anti-Macrophage Migration Inhibitory Factor Antibodies Inhibit Growth of Human Prostate Cancer Cells In Vitro and In Vivo", MOLECULAR CANCER THERAPEUTICS, (20130701), vol. 12, no. 7, doi:10.1158/1535-7163.MCT-12-0988, ISSN 1535-7163, pages 1223 - 1234, XP055199203 [A] 1-36 * the whole document *
INTERNATIONAL-SEARCH-REPORT- MEYER-SIEGLER KATHERINE L ET AL, "Inhibition of macrophage migration inhibitory factor decreases proliferation and cytokine expression in bladder cancer cells", BMC CANCER, BIOMED CENTRAL, LONDON, GB, (20040712), vol. 4, no. 1, doi:10.1186/1471-2407-4-34, ISSN 1471-2407, page 34, XP021004633 [A] 1-36 * the whole document *
OPPOSITION- Anonymous, "Guidance for Industry. Estimating the maximum safe starting dose in initial clinical trials for therapeutics in adult healthy volunteers", Guidance for Industry, U.S. department of health and human services/ Food and drug administration/ Center for drug evaluation and research (CDER), pages 1 - 3 + 1, XP002565369-
OPPOSITION- CHESNEY J. et al., "An essential role for macrophage migration inhibitory factor (MIF) in angiogenesis and the growth of a murine lymphoma", Mol Med., (19990000), vol. 5, no. 3, pages 181 - 191, XP001013386-
OPPOSITION- Vogel Hans G, Et Al, "Dose finding in Single Dose Study by Allometric Scaling", Drug Discovery and Evaluation: Methods in Clinical Evaluation: Methods in Clinical Pharmacology, (20110101), pages 10 - 13, XP055879808-
OPPOSITION- KERSCHBAUMER RJ. et al., "Neutralization of 2012 macrophage migration inhibitory factor (MIF) by fully human antibodies correlates with their specificity for the beta-sheet structure of MIF", J Biol Chem., (20120000), vol. 287, no. 10, doi:10.1074/jbc.M111.329664, pages 7446 - 7455, XP055050382
OPPOSITION- F. Hussain et al, "Human Anti-Macrophage Migration Inhibitory Factor Antibodies Inhibit Growth of Human Prostate Cancer Cells In Vitro and In Vivo", Molecular Cancer Therapeutics, American Association for Cancer Research, Inc., (20130701), vol. 12, no. 7, doi:10.1158/1535-7163.MCT-12-0988, ISSN 15357163, pages 1223 - 1234, XP055199203

Download Citation Report

Get a free citation report including examiner, opposition, and international search citations.

Get Citation Report

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents